Study Finds Significantly More Adults Living with Diabetic Retinopathy in the United States than Previously Estimated

New study finds that nearly 10 million people in the US with diabetes have diabetic retinopathy A new study published today in JAMA Ophthalmology, “Prevalence of Diabetic Retinopathy in the US in 2021,” found that in 2021, an estimated 9.6 million people in the United States (26.4 percent of those with diabetes) had diabetic retinopathy

Onward Clinical Trial for Geographic Atrophy (GA)

If you or someone you know has been diagnosed with an advanced form of dry age-related macular degeneration (AMD) called geographic atrophy (GA), you may be interested in learning about a new clinical research study. Doctors and researchers want to see if an investigational medicine called danicopan [da-NIH-co-pan] can safely help slow or stop this

New Study Finds Social Determinants of Health are Associated with Vision Loss

A new study from NORC at the University of Chicago, and the Centers for Disease Control and Prevention (CDC), Division of Diabetes Translation, entitled “Association Between Social Determinants of Health (SDOH) and Examination-Based Vision Loss vs Self-Reported Vision Measures” published in JAMA Ophthalmology, found that SDOH across multiple domains were associated with vision loss. The

The NEPTUNE Research Study

The NEPTUNE research study is seeking volunteers to assess the safety and effectiveness of an investigational treatment for adults with non-infectious uveitis. This is a randomized, double-masked, dose-ranging phase 2 study to evaluate the efficacy and safety of oral brepocitinib in adults with active intermediate-, posterior or panuveitis. Eligible participants will be randomly assigned 2:1

New study finds higher AMD prevalence & high county variation

New study from leading researchers at NORC at the University of Chicago, the Institute for Health Metrics and Evaluation, University of Michigan, and the Centers for Disease Control and Prevention, shows higher prevalence rates of AMD, a leading cause of vision loss in the United States A new study “The Prevalence of Age-Related Macular Degeneration

Recipients of the 2022 Prevent Blindness Jenny Pomeroy Award for Excellence in Vision and Public Health and Rising Visionary Award Announced

Prevent Blindness has announced the recipient of the 2022 Jenny Pomeroy Award for Excellence in Vision and Public Health as VOSH/International (V/I). Additionally, Prevent Blindness is pleased to announce the co-recipients of the third annual “Rising Visionary Award” as Marissa K. Shoji, MD, Bascom Palmer Eye Institute, and Hursuong Vongsachang, MPH, Johns Hopkins University School

Prevent Blindness Thanks James Jorkasky for Two Decades of Work Contributing to Advancements in Vision and Eye Health

Prevent Blindness thanks James (Jim) Jorkasky for his nearly two decades of work contributing to advancements in vision and eye health.  Since 2003, Jim has served as the Executive Director of the National Alliance for Eye and Vision Research (NAEVR), an advocacy organization, and the Alliance for Eye and Vision Research (AEVR), an educational foundation. 

Virtual Workshop: Public Health and Research Applications of the CDC’s Vision and Eye Health Surveillance System (VEHSS)

Virtual Workshop: Public Health and Research Applications of the CDC’s Vision and Eye Health Surveillance System (VEHSS) Prevent Blindness will be hosting a FREE virtual workshop on the Public Health and Research Applications of the CDC’s Vision and Eye Health Surveillance System (VEHSS). This workshop will focus on how to use the CDC’s VEHSS and how